Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy M Gulick

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
AIDS Research and Human Retroviruses|May 9, 2008
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infectionJeffrey A Anderson, Hongyu Jiang, Xiao Ding, et al.
Journal of the International AIDS Society|June 21, 2012
Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in HaitiMacarthur Charles, Paul D Leger, Patrice Severe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York CityMatthew S Simon, Don Weiss, Anita Geevarughese, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359Courtney V Fletcher, Marcia A Testa, Richard C Brundage, et al.
The Journal of Infectious Diseases|July 14, 2009
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjectsSamir K Gupta, Lauren Komarow, Roy M Gulick, et al.
AIDS Research and Human Retroviruses|September 25, 2010
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individualsCecilia M Shikuma, Heather J Ribaudo, Yu Zheng, et al.
Journal of Virology|November 18, 2011
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drugOpass Putcharoen, Sun Hee Lee, Timothy J Henrich, et al.
Plos One|June 23, 2023
Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305Elias P Rosen, Nicole White, William M Gilliland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United StatesMichael P Girouard, Paul E Sax, Robert A Parker, et al.
The Journal of Infectious Diseases|August 6, 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
AIDS Research and Human Retroviruses|May 9, 2008
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infectionJeffrey A Anderson, Hongyu Jiang, Xiao Ding, et al.
Journal of the International AIDS Society|June 21, 2012
Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in HaitiMacarthur Charles, Paul D Leger, Patrice Severe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York CityMatthew S Simon, Don Weiss, Anita Geevarughese, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359Courtney V Fletcher, Marcia A Testa, Richard C Brundage, et al.
The Journal of Infectious Diseases|July 14, 2009
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjectsSamir K Gupta, Lauren Komarow, Roy M Gulick, et al.
AIDS Research and Human Retroviruses|September 25, 2010
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individualsCecilia M Shikuma, Heather J Ribaudo, Yu Zheng, et al.
Journal of Virology|November 18, 2011
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drugOpass Putcharoen, Sun Hee Lee, Timothy J Henrich, et al.
Plos One|June 23, 2023
Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305Elias P Rosen, Nicole White, William M Gilliland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United StatesMichael P Girouard, Paul E Sax, Robert A Parker, et al.
The Journal of Infectious Diseases|August 6, 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.
Pageof 16